A total of 25 (59.52%) patients were considered exhibiting clinical treatment success, which was defined as improvements of clinical symptoms and parameters including body temperature, biochemistry indicators of infection (white cell count in adult ≤109, C-reactive protein ≤10 mg/L, procalcitonin <0.05 ng/ml, and erythrocyte sedimentation rate <15 mm/h), and clinician-documented improvement at the end of treatment. Here, CRP is linked to infection.